Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia
- Author
- SCHUURHUIS, G. J1 ; BROXTERMAN, H. J; LANKELMA, J; PINEDO, H. M; OSSENKOPPELE, G. J1 ; BAAK, J. P. A; EEKMAN, C. A; KUIPER, C. M; FELLER, N; VAN HEIJNINGEN, T. H. M; KLUMPER, E; PIETERS, R
[1] Free univ. hosp., dep. hematology, 1081 HV Amsterdam, Netherlands - Source
Clinical cancer research. 1995, Vol 1, Num 1, pp 81-93 ; ref : 27 ref
- ISSN
- 1078-0432
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Chimiothérapie Cytarabine Cytotoxicité Efficacité traitement Expression génique Homme In vitro In vivo Leucémie myéloblastique Phénotype Prédiction Résistance multiple Sensibilité résistance Traitement Glycoproteine P Gène MRP Gène mdr1 Hémopathie maligne
- Keyword (en)
- Antineoplastic agent Chemotherapy Cytotoxicity Treatment efficiency Gene expression Human In vitro In vivo Acute myelocytic leukemia Phenotype Prediction Multiple resistance Sensitivity resistance Treatment Malignant hemopathy
- Keyword (es)
- Anticanceroso Quimioterapia Citotoxicidad Eficacia tratamiento Expresión genética Hombre In vitro In vivo Leucemia mieloblástica Fenotipo Predicción Resistencia múltiple Sensibilidad resistencia Tratamiento Hemopatía maligna
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R01 General aspects
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3609366
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:1:\"1\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"81\";s:8:\"\u0000*\u0000epage\";s:2:\"93\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCHUURHUIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BROXTERMAN, H. J\";i:1;s:11:\"LANKELMA, J\";i:2;s:12:\"PINEDO, H. M\";i:3;s:18:\"OSSENKOPPELE, G. J\";i:4;s:13:\"BAAK, J. P. A\";i:5;s:12:\"EEKMAN, C. A\";i:6;s:12:\"KUIPER, C. M\";i:7;s:9:\"FELLER, N\";i:8;s:23:\"VAN HEIJNINGEN, T. H. M\";i:9;s:10:\"KLUMPER, E\";i:10;s:10:\"PIETERS, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:1:\"1\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"81\";s:8:\"\u0000*\u0000epage\";s:2:\"93\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCHUURHUIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BROXTERMAN, H. J\";i:1;s:11:\"LANKELMA, J\";i:2;s:12:\"PINEDO, H. M\";i:3;s:18:\"OSSENKOPPELE, G. J\";i:4;s:13:\"BAAK, J. P. A\";i:5;s:12:\"EEKMAN, C. A\";i:6;s:12:\"KUIPER, C. M\";i:7;s:9:\"FELLER, N\";i:8;s:23:\"VAN HEIJNINGEN, T. H. M\";i:9;s:10:\"KLUMPER, E\";i:10;s:10:\"PIETERS, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:1:\"1\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"81\";s:8:\"\u0000*\u0000epage\";s:2:\"93\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCHUURHUIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BROXTERMAN, H. J\";i:1;s:11:\"LANKELMA, J\";i:2;s:12:\"PINEDO, H. M\";i:3;s:18:\"OSSENKOPPELE, G. J\";i:4;s:13:\"BAAK, J. P. A\";i:5;s:12:\"EEKMAN, C. A\";i:6;s:12:\"KUIPER, C. M\";i:7;s:9:\"FELLER, N\";i:8;s:23:\"VAN HEIJNINGEN, T. H. M\";i:9;s:10:\"KLUMPER, E\";i:10;s:10:\"PIETERS, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:1:\"1\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"81\";s:8:\"\u0000*\u0000epage\";s:2:\"93\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCHUURHUIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BROXTERMAN, H. J\";i:1;s:11:\"LANKELMA, J\";i:2;s:12:\"PINEDO, H. M\";i:3;s:18:\"OSSENKOPPELE, G. J\";i:4;s:13:\"BAAK, J. P. A\";i:5;s:12:\"EEKMAN, C. A\";i:6;s:12:\"KUIPER, C. M\";i:7;s:9:\"FELLER, N\";i:8;s:23:\"VAN HEIJNINGEN, T. H. M\";i:9;s:10:\"KLUMPER, E\";i:10;s:10:\"PIETERS, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:1:\"1\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"81\";s:8:\"\u0000*\u0000epage\";s:2:\"93\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCHUURHUIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BROXTERMAN, H. J\";i:1;s:11:\"LANKELMA, J\";i:2;s:12:\"PINEDO, H. M\";i:3;s:18:\"OSSENKOPPELE, G. J\";i:4;s:13:\"BAAK, J. P. A\";i:5;s:12:\"EEKMAN, C. A\";i:6;s:12:\"KUIPER, C. M\";i:7;s:9:\"FELLER, N\";i:8;s:23:\"VAN HEIJNINGEN, T. H. M\";i:9;s:10:\"KLUMPER, E\";i:10;s:10:\"PIETERS, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:215:\"Functional multidrug resistance phenotype associated with combined overexpression of Pgp\/MDR1 and MRP together with 1-\u03b2-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
